Comparative Study of Secondary Prophylaxis for SBP

NCT06827756 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Spontaneous Bacterial Peritonitis
Cirrhoses, Liver
Ascites

Interventions

DRUG: Norfloxacin 400 MG
DRUG: Nitazoxanide 500 MG
DRUG: Colistin

Sponsor

Tanta University